ipamorelin bloating Sermorelin vs CJC-1295/Ipamorelin: Complete Comparison Guide (2026) Tesamorelin / CJC / Ipamorelin

PMID: 27847966 | doi:10.1007/s00109-016-1488-y Chang CH et al

Statements Data availability statement The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation

The extended halflife of approximately 7 days is due to albumin binding and resistance to DPP4 degradation, enabling convenient onceweekly dosing [1]

78 National Institute of Diabetes and Digestive and Kidney Diseases

However, as with all research compounds, it is essential to approach their use with caution, prioritize product quality, and remain mindful of regulatory and safety considerations

What can be said is that they sit on very different evidence tiers: tesamorelin is FDA-approved with multiple Phase 3 randomized trials for reducing visceral fat in HIV-associated lipodystrophy, while CJC-1295 is unapproved, with only two small early-phase human studies measuring GH and IGF-1 surrogates